Oct 12, 2017 12:31 pm UTC| Business
AUSTIN, Texas, Oct. 12, 2017 -- Ideal Power Inc. (NASDAQ:IPWR), an innovative power conversion technology company, will hold a conference call on Thursday, November 9, 2017 at 4:30 p.m. Eastern time to discuss its...
Oct 12, 2017 12:31 pm UTC| Business
Anaheim, CA, Oct. 12, 2017 -- LiveWire Ergogenics, Inc. (OTC PINK: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, today announced that it has...
IXYS Integrated Circuits Division Introduces High Current MOSFET Power Solid State Relay (SSR)
Oct 12, 2017 12:31 pm UTC| Business
BEVERLY, Mass., Oct. 12, 2017 -- IXYS Integrated Circuits Division (ICD), Inc., a wholly owned subsidiary of IXYS Corporation (NASDAQ:IXYS), announced the immediate availability of the CPC1705Y, a 60V, 3.25A,...
Blucora to Announce Third Quarter 2017 Financial Results Thursday, October 26, 2017
Oct 12, 2017 12:31 pm UTC| Business
IRVING, Texas, Oct. 12, 2017 -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled financial solutions to consumers, small businesses and tax professionals, will announce its third quarter 2017...
Skyline Medical to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
Oct 12, 2017 12:31 pm UTC| Business
MINNEAPOLIS, Oct. 12, 2017 -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that...
LifeSci Advisors Continues Expansions with New Boston Office
Oct 12, 2017 12:30 pm UTC| Business
Providing Investor Relations, Public Relations, Corporate Communications and Capital Markets Advisory Services to Greater Boston and Cambridge Life Sciences Companies NEW YORK, Oct. 12, 2017 -- LifeSci Advisors, an...
Oct 12, 2017 12:30 pm UTC| Business
SAN RAMON, Calif., Oct. 12, 2017 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...